4D Molecular Therapeutics

Updated: July 26, 2026
David Kirn - CEO, Co-founder, Chairman
David Kirn - CEO, Co-founder, Chairman
Country: USA | Funding: $902.5M (+)
Founded: 2013

Website: https://www.4dmoleculartherapeutics.com/

4D Molecular Therapeutics is unlocking the full potential of the gene therapy field. Our customized AAV vectors can deliver genes to any cell in the body to eradicate disease.




Competitors